(5-Chloro-2-(trifluoromethyl)phenyl)boronic acid, 95.0%, 1g

1,1-Difluoro-2-isocyanato-ethane, 1g

5-(Thiophen-3-yl)pyridin-2-amine, 98%, 50mg

Benzyl 3-bromo-4-chloro-5-methylbenzoate, 98%, 500mg

2-(4-Nitrophenyl)quinazolin-4(1H)-one, 97%, 100mg

6-Chloropyrimido[5,4-d]pyrimidin-4(3H)-one, 95.0%, 250mg

TERT-BUTYL 3-AMINO-4-FLUOROPIPERIDINE-1-CARBOXYLATE, 95.0%, 250mg

Cyclohexanemethylamine Hydroiodide>98.0%(N)(T)5g

Microliter syringe GASTIGHT® series 1700 Point type 3, 500 µl, 1750 RNR, 1 piece

Benzyl (3-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)carbamate, 95.0%, 100g

Ethyl 2-(2-azaspiro[3.3]heptan-6-yl)acetate 2,2,2-trifluoroacetate, 98%, 250mg

2-Amino-4,6-diphenylpyrimidine>98.0%(GC)(T)5g

Trisodium phosphate (dodecahydrate), 1kg